News
18 April 2024
BAP Pharma Announces Grand Opening Ceremony for New US Headquarters in Somerset, NJ
BAP Pharma announced today that the Grand Opening Ceremony of its new US headquarters will be held on Wednesday, 24th of April 2024.
SOMERSET, N.J.– (BUSINESS WIRE) – BAP Pharma will welcome guests and dignitaries to the Grand Opening Ceremony of its new headquarters on Randolph Road with a formal ribbon cutting ceremony, speeches, and exclusive tours of the new facility.
First setting up US operations in Landing, New Jersey in 2016, BAP Pharma experienced extraordinary success and growth fuelled by new customer acquisition, diversification, and expansion into new markets. This resulted in the formation of two new divisions to complement the original Comparator Sourcing business – Clinical Secondary Packaging and Labelling and Medicines Access – and necessitated the move to a much larger facility with a broader range of capabilities.
BAP Pharma’s new US headquarters are in a modern, state-of-the-art 28,000 sq. ft. facility and are fully licensed by the New Jersey State Department of Health. Some of its capabilities include a 24-hour temperature-controlled and monitored warehouse with ambient (+15°C to +25°C), cold (+2°C to +8°C), and freezer (-20°C) storage facilities.
Additionally, BAP Pharma’s US facility can provide in-house label design and print, temperature-controlled clinical secondary packaging, and just-in-time/on-demand labelling.
Dr. Bashir Parkar, Founder and Managing Director of BAP Pharma, established the company in 2011 to provide the high-quality supply of comparator drugs for clinical trials to help overcome the common barriers to treatment for patients. By providing a total global solution as a top-tier service provider, BAP Pharma delivers medicines to patients at the right time, at the right place, and at the right temperature.
“We are excited to have invested into a new modern facility in New Jersey, which will enable further development and growth in our key business area of Comparator Sourcing, as well as now offering Clinical Secondary Packaging & Labelling and Medicines Access services. The facility and location proved a perfect fit for our company. Its proximity to a significant number of global pharmaceutical and biotechnology companies, including our current clients, made it particularly attractive. New Jersey’s excellent transportation network also enhances our ability to deliver products quickly and efficiently throughout the region and around the world.”
Dr. Bashir Parkar, Founder and Managing Director of BAP Pharma.
For more information on the Grand Opening Ceremony, please contact us at [email protected]
You Might Also Like

BAP Pharma ranked in FEBE Growth 100 List
BAP Pharma are honoured to receive an award from FEBE Growth 100 and to have been ranked within the 2022 list of the fastest growing, founder-led, privately-owned UK businesses. BAP Pharma receiving the FEBE Growth 100 Award – pictured left to right – Award Partner Anthony Higson from Pictet, FEBE
Read More
BAP Pharma Hosts Grand Opening Ceremony for its New US Headquarters
SOMERSET N.J. (BUSINESS WIRE) On Wednesday 24th April 2024 BAP Pharma hosted the Grand Opening Ceremony for its new US headquarters in Somerset NJ. The weather could not have been better for an exciting day of events as BAP Pharma welcomed guests and dignitaries to the Grand Opening Ceremony of
Read More
BAP Pharma Granted Clinical Secondary Packaging and Labelling Licence
BAP Pharma are pleased to announce that the Government of Upper Bavaria (Regierung von Oberbayern) have granted a Clinical Secondary Packaging and Labelling licence, to our German facility. The new licence will enable BAP Pharma to offer bespoke Clinical Trial Secondary Packaging and Labelling services, to complement our award-winning Comparator
Read More